Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Nasopharyngeal Carcinoma × Radiation × Clear all

Sponsor

Conditions

Glioblastoma 21 Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 13 Rectal Neoplasms 11 Prostatic Neoplasms 11 Gliosarcoma 11 Esophageal Neoplasms 9 Brain Neoplasms 9 Uterine Cervical Neoplasms 8 Lung Neoplasms 8 Adenocarcinoma Of Esophagus 8 Neoplasms 7 Head and Neck Neoplasms 7 Pancreatic Neoplasms 6 Central Nervous System Neoplasms 6 Carcinoma, Squamous Cell 6 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 5 Glioma 5 Astrocytoma 5 Urinary Bladder Neoplasms 4 Melanoma 4 Leukemia, Myeloid, Acute 4 Endometrial Neoplasms 4 Burkitt Lymphoma 4 Breast Neoplasms, Male 4 Rhabdomyosarcoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Cisplatin 4 pembrolizumab 2 Nivolumab 2 Fluorouracil 2 Carboplatin 2 toripalimab 1 spartalizumab 1 fludarabine phosphate 1 fludarabine 1 cc-486 1 camrelizumab 1 Vorinostat 1 Range of Motion, Articular 1 Radiotherapy 1 Radiosurgery 1 Protons 1 Platinum 1 Methylprednisolone 1 Medicare Part B 1 Laryngoscopes 1 Gemcitabine 1 Docetaxel 1 Cyclophosphamide 1 Cetuximab 1 Bevacizumab 1 Azacitidine 1 Adrenal Cortex Hormones 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡